Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
暂无分享,去创建一个
[1] J. Kastelein,et al. Surrogate markers in clinical trials--challenges and opportunities. , 2009, Atherosclerosis.
[2] Srinivas R Sadda,et al. Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. , 2009, American journal of ophthalmology.
[3] P A Keane,et al. Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography , 2009, British Journal of Ophthalmology.
[4] Srinivas R Sadda,et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[5] Christian Ahlers,et al. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. , 2009, Investigative ophthalmology & visual science.
[6] Srinivas R Sadda,et al. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[7] A. Tsujikawa,et al. Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration. , 2009, American journal of ophthalmology.
[8] G. Rubin,et al. Intersession repeatability of contrast sensitivity scores in age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[9] Srinivas R Sadda,et al. EFFECT OF RANIBIZUMAB RETREATMENT FREQUENCY ON NEUROSENSORY RETINAL VOLUME IN NEOVASCULAR AMD , 2009, Retina.
[10] Richard F Spaide,et al. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. , 2009, American journal of ophthalmology.
[11] P. Kaiser,et al. Photoreceptor status after antivascular endothelial growth factor therapy in exudative age-related macular degeneration , 2009, British Journal of Ophthalmology.
[12] Philip J Rosenfeld,et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. , 2009, American journal of ophthalmology.
[13] P. Keane,et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.
[14] C. Bunce,et al. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design , 2008, Trials.
[15] Christian Ahlers,et al. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration. , 2008, Ophthalmology.
[16] P. Keane,et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[17] P. Keane,et al. Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis , 2008, British Journal of Ophthalmology.
[18] Rhea Lloyd,et al. Food and Drug Administration approval process for ophthalmic drugs in the US , 2008, Current opinion in ophthalmology.
[19] U Chakravarthy,et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.
[20] F. Ferris,et al. Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. , 2008, Investigative ophthalmology & visual science.
[21] Gabriel Coscas,et al. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. , 2007, American journal of ophthalmology.
[22] Paul G. Updike,et al. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[23] Ziqiang Wu,et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.
[24] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[25] K. Eng,et al. Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.
[26] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[27] R. Hogg,et al. Visual function and dysfunction in early and late age-related maculopathy , 2006, Progress in Retinal and Eye Research.
[28] Richard F Spaide,et al. INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2006, Retina.
[29] J. Sunness. Choroidal neovascularisation and atrophy , 2006, British Journal of Ophthalmology.
[30] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[31] Michael Stur,et al. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. , 2003, Ophthalmology.
[32] T. Cox,et al. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.
[33] A. Bird,et al. Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. , 2002, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie.
[34] K L Petre,et al. Visual function and subjective quality of life compared in subjects with acquired macular disease. , 2000, Investigative ophthalmology & visual science.
[35] Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.
[36] D. M. Gass,et al. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment , 1987 .
[37] P. Liao,et al. Stereoscopic Atlas of Macular Diseases. Diagnosis and Treatment , 1987, The Yale Journal of Biology and Medicine.